Joints & movement
Does a GLP-1 help knee arthritis pain?
A randomised trial found large reductions in knee pain on semaglutide. What it measured, what it did not, and why quadriceps strength still matters.
Read the article →Plain-language explainers on the questions people actually ask about Ozempic, Wegovy, Mounjaro, and Zepbound. Every claim is cited to the research, and every article says so wherever the evidence runs thin.
Joints & movement
A randomised trial found large reductions in knee pain on semaglutide. What it measured, what it did not, and why quadriceps strength still matters.
Read the article →Bone & skeleton
Rapid weight loss costs bone as well as muscle. What has actually been measured in GLP-1 users, where the fracture evidence conflicts, and what protects the skeleton.
Read the article →GLP-1 & muscle
A large share of GLP-1 weight loss is lean mass, not fat. What the trial data shows, and the two things proven to protect your muscle.
Read the article →Nutrition
Your target in grams per kilogram, why it is so hard on a suppressed appetite, and the mechanics of hitting it anyway.
Read the article →Nutrition
Not all protein protects muscle equally, and on a GLP-1 your intake is limited, so quality matters. A direct comparison, and why collagen is the wrong pick.
Read the article →Reference
The key statistics on GLP-1 muscle loss, each cited to published research and free to reference: how much of the weight is lean mass, the protein target, and more.
See the numbers →Supplements
The kidney myth, the early scale bump, what the evidence supports, and the one limitation no honest source can hide.
Read the article →Training
Why bodyweight training works when it is loaded and progressed, and how to make it harder without a single barbell.
Read the article →Maintenance
The weight-regain data, the sarcopenic-obesity risk, and why the muscle you keep now is your reserve for later.
Read the article →Comparison
What the separate trials actually show, why cross-trial comparisons are limited, and what that means for you.
Read the article →Body composition
The signals worth watching, why the scale and even DXA can mislead, and the one thing you can track at home.
Read the article →Training
The movement patterns that matter most, and why effort and progression beat any particular piece of equipment.
Read the article →Emerging therapies
The biggest weight loss yet reported for a GLP-1-class drug, and why the lean-mass data behind it is much thinner than for Ozempic or Mounjaro.
Read the article →Body composition
Plateaus are normal by around a year in. Why the stall may have as much to do with muscle and metabolic adaptation as with fat loss finishing.
Read the article →Body composition
These viral terms get treated as skin-deep problems. Here is what's actually fat loss, what's skin and volume, and what's genuinely lean-mass loss.
Read the article →Nutrition
Concrete, realistic foods and shakes for the days nausea or a suppressed appetite make eating hard, with approximate protein per serving.
Read the article →Women's health
Menopause already puts muscle and bone on a faster downward slope. Why the math changes once a GLP-1 is added, and what the research does and does not show.
Read the article →Body composition
A concrete, five-part protocol using a chair, a tape measure, and your phone, each part drawn from a real clinical or research tool.
Read the article →Training & recomposition
What the body-recomposition evidence shows, what no trial has tested yet in GLP-1 users, and how to set a realistic goal.
Read the article →Nutrition
Why reduced intake raises deficiency risk, what the real incidence data shows, and food-first ways to close the gap.
Read the article →Emerging research
An honest look at an emerging question: what rapid weight loss does to connective tissue, and how thin the direct GLP-1 tendon-injury evidence still is.
Read the article →Type 2 diabetes
Most muscle research excludes type 2 diabetes. What the T2D-specific trial data shows about weight loss, lean mass, and what protects it.
Read the article →Nutrition
Plant protein and a suppressed appetite is a hard combination, not an impossible one. Real per-serving numbers, verified against USDA data.
Read the article →Training
"Can't I just do cardio?" What the randomized-trial evidence actually shows about each, and how to combine them.
Read the article →Older adults
Older adults carry less muscle reserve to begin with and show a real-world fracture signal the obesity trials have not. Why the off-ramp plan changes after 65.
Read the article →Body composition
They get blamed on each other constantly. What is dermal, what is muscle, what actually helps each, and what realistically does not resolve on its own.
Read the article →Body composition
What each scan actually measures, how accurate they are against each other, what they cost, and whether a free calculator gets you most of the way there.
Read the article →Nutrition
Stacking a compressed eating window on top of a GLP-1's appetite suppression sounds efficient. What the evidence shows, and where it's still extrapolation.
Read the article →Training
You have a membership but have never lifted. Which exercises to start with, sets, reps, frequency, and how to progress safely while your bodyweight changes fast.
Read the article →Nutrition
You already know how much protein to eat. What meal distribution, the leucine threshold, and the "anabolic window" research actually shows.
Read the article →Reference
The escalation steps printed on the labels for Ozempic, Wegovy, Mounjaro and Zepbound, plus where retatrutide actually stands. A reference, not dosing advice.
Read the reference →The articles explain the evidence. The guides turn it into an exact protocol: routines, protein tables, sample days, and timelines. Start with a $1 mini-guide, or get the full 30-page handbook for $5.